4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-22-054902
Chairman and CEO bought 69,400 shares at an average $0.28 ($19,288)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2022-10-24 | Purchase | +7,500 | $0.22 | $1,650 | 11,898,857 | D |
| Niihara Yutaka Chairman and CEO | 2022-10-25 | Purchase | +20,000 | $0.26 | $5,200 | 11,918,857 | D |
| Niihara Yutaka Chairman and CEO | 2022-10-26 | Purchase | +11,900 | $0.27 | $3,213 | 11,930,757 | D |
| Niihara Yutaka Chairman and CEO | 2022-10-27 | Purchase | +22,500 | $0.27 | $6,075 | 11,953,257 | D |
| Niihara Yutaka Chairman and CEO | 2022-10-28 | Purchase | +7,500 | $0.42 | $3,150 | 11,960,757 | D |
| Open-market purchases · 69,400 sh · avg $0.28 · $19,288 | |||||||
Loading xslF345X03/doc4.xml…